InvestorsHub Logo
Followers 1
Posts 55
Boards Moderated 0
Alias Born 03/26/2014

Re: Darwinian post# 2055

Tuesday, 08/11/2015 6:47:18 PM

Tuesday, August 11, 2015 6:47:18 PM

Post# of 3835
There is plenty of potential good news for 2016 with the psoriasis, melanoma and FX (Liver Fibrosis) trial. 2016 will definitely be the year for demonstrating efficacy for numerous diseases - IMHO

and the FX and CX trial results (when considered together) could also support accelerated approval - IMHO. If GR-MD-02 can actually reduce portal pressure, that would be a huge breakthrough for the treatment of liver disease.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News